BioSpace News Archive

In January 2018, Genocea completed a $55 million equity financing, including significant investments from NEA and Vivo.

SAM was initially developed to be user friendly and support the commercialization of PMX by removing the need to use more cumbersome dialysis instruments by providing specific hemoperfusion capabilities

The Company has filed new patent applications related to the discovery.

This drug-device combination product utilizes the Antares Pharma QuickShot device which was specifically developed to deliver a rapid injection of highly viscous drug products such as progesterone in oil, through a fine gauge nonvisible needle.

AmerisourceBergen Corporation, a global healthcare solutions leader, released the following comment regarding the announcement by the U.S. Drug Enforcement Administration (“DEA”) that it would add a new feature to its ARCOS Online Reporting System to enable manufacturers and distributors to view the number of competitors selling controlled substances to prospective customers within a six-month window.

Ipsen announced Dysport (abobotulinumtoxinA) data will be presented today in two oral presentations at the annual meeting of the Association of Academic Physiatrists (AAP) being held in Atlanta, February 13-17, 2018.

Gen. Grange assumes the seat held by Stuart Davidson, who has stepped down from the position of company director that Mr. Davidson has held since 2011.

The assets acquired are soft tissue core needle biopsy products sold under the trade names of Achieve Programmable Automatic Biopsy System, Temno Biopsy System, Tru-Cut Biopsy Needles as well as Aspira Pleural Effusion Drainage Kits, and the Aspira Peritoneal Drainage System.

In addition, in order to secure additional working capital, the Company has also mandated Lodge Corporate Pty Ltd to assist in a proposed private placement of up to 324.7 million new GTG fully paid ordinary shares at an issue price of 0.014c per GTG share.

Avid Bioservices intends to use the cash for the expansion of its contract manufacturing business and general corporate purposes.